Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Misocholic Tab
- Development stage
- Phase 3
- Lead developer
- Hanoi Medical University
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Misocholic Tab is a standardized Vietnamese herbal formulation developed for the treatment of hepatic disorders, including chronic hepatitis and non-viral elevated liver enzymes associated with alcohol-related liver disease, drug-induced liver injury, or non-alcoholic fatty liver disease (NAFLD). The formulation is composed of three primary active ingredients: pig bile extract (*Extractum Fel Suillum*), artichoke extract (*Extractum Cynarae Succus*), and garlic bulb (*Bulbus Allii Sativi*). These components work synergistically to provide anti-inflammatory, hepatoprotective, choleretic, antibacterial, and antioxidant effects. Misocholic Tab is currently being evaluated in a Phase 3 clinical trial sponsored by Hanoi Medical University to assess its efficacy and safety in adults with mild to moderate elevation of alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST).
- Brand names
- Misocholic Tab
- Other names
- MisocholicMisocholic film-coated tablets
Beyond the preview
Go deeper on Misocholic Tab.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Misocholic Tab.